← Eichor
Study identifier: NCT05202964 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)

Condition: Drug-Related Side Effects and Adverse Reactions · Treatment Adherence and Compliance  ·  Sponsor: Hospices Civils de Lyon

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Bone and joint infections (BJI) are most often bacterial infections that can occur after surgery or de novo. They are rarely fatal in the short term, but are associated with significant morbidity, impaired quality of life and significant costs. Treatment of BJI is based on antibiotic therapy, often combined with surgery. Antibiotic therapy, at high doses, lasts a minimum of 6 weeks. It can be responsible for severe adverse effects. These characteristics (prolonged duration, multiple daily doses, and adverse effects) are known to negatively affect treatment adherence in general.

This description comes directly from the study's public registry record.

Talk to the study team

Tristan FERRY, MD, PHD  ·  4 26 73 29 38  ·  tristan.ferry@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hospices Civils de LyonLyon, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05202964